Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

SILO logo
Silo Pharma
CM
CMCVentures
Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
86.8% undervalued intrinsic discount
234.00%
Revenue growth p.a.
6users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
7 days ago author updated this narrative
DOCN logo
DigitalOcean Holdings
NE
Nenad
Community Contributor

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

1. Current Business (Present Narrative): DigitalOcean is a cloud computing provider focused on small and medium-sized businesses (SMBs) , startups, and developers.
View narrative
US$50.00
FV
43.5% undervalued intrinsic discount
18.62%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
4 months ago author updated this narrative

Community Investing Ideas

Load previous narratives
CRN logo
Coronado Global Resources
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts

Mammoth And Buchanan Projects Will Drive Efficiency And Stability

Key Takeaways Completion of key projects is set to boost production, enhance revenue, and improve margins through cost per ton reduction. Cost-cutting and liquidity strategies aim to lessen expenses and improve cash flow, bolstering financial stability amidst market shifts.
View narrative
AU$0.38
FV
55.3% undervalued intrinsic discount
3.52%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
DCTH logo
Delcath Systems
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

HEPZATO Launch And European Expansion Will Expand Treatment Access

Key Takeaways Expansion in U.S. treatment centers and commercial teams is expected to drive significant revenue growth and improve operational efficiencies. European market strategy and new R&D initiatives could lead to strategic revenue growth and future innovations.
View narrative
US$22.50
FV
47.9% undervalued intrinsic discount
60.03%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
PSFE logo
Paysafe
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

Digital Wallet Launches And Revolut Alliance Will Drive Future Success

Key Takeaways Paysafe's focus on high-growth areas and strategic divestitures is expected to improve revenue stability and drive growth. Expansion of sales force and strategic partnerships are projected to significantly boost client acquisition and enhance revenue.
View narrative
US$17.83
FV
16.2% undervalued intrinsic discount
3.22%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
5 days ago author updated this narrative